Carmell Therapeutics Corporation (XAGE) - Total Stockholders' Equity
Longevity Health Holdings (XAGE) develops innovative plasma-based bio-cosmetic products for tissue restoration, protecting profitability through exclusive patents. This price chart shows the stock's performance at -0.00, although the business remains susceptible to skincare trends and promotional expenses. The stability of the longevity center network is supported by immediate patient payments, ensuring rapid cash turnover and the coverage of expenses.
Carmell Therapeutics - analytical breakdowns and key metrics (XAGE)
The technical re-equipment of bottling lines in Longevity Health Holdings (XAGE) laboratories directly impacts the value of non-current assets and the overall capitalization of the business. Through the GURU.Markets tool, the investor tracks the volume of equity on the balance sheet as the difference between all property rights and liabilities, which allows for an assessment of the company's real foundation and prevents overpaying for market noise.